Cargando…

Do statins improve outcomes for patients with non-small cell lung cancer? A systematic review and meta-analysis protocol

INTRODUCTION: Lung cancer is the most common neoplasm and the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC), accounting for 85% of all lung cancer cases, is frequently diagnosed at an advanced and metastatic stage. In addition, survival of patients with NSCLC ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Feng, Liu, Guangyu, Roudi, Raheleh, Huang, Qi, Swierzy, Marc, Ismail, Mahmoud, Zhao, Song, Rueckert, Jens-Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144318/ https://www.ncbi.nlm.nih.gov/pubmed/30206083 http://dx.doi.org/10.1136/bmjopen-2018-022161

Ejemplares similares

Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol
por: Rasti, Arezoo, et al.
Publicado: (2016)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Dynamic nomogram for long-term survival in patients with non-small cell lung cancer after pneumonectomy
por: Wang, Zi-Ming, et al.
Publicado: (2021)

The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation
por: Iarrobino, Nick A., et al.
Publicado: (2018)

Immune-related adverse events associated with PD-1 and PD-L1 inhibitors for nonsmall cell lung cancer: Protocol for a systematic review and meta-analysis
por: Sun, Xiaoying, et al.
Publicado: (2017)

Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics
por: Saeednejad Zanjani, Leili, et al.
Publicado: (2019)

Risk factors for acute exacerbation of interstitial lung disease during chemotherapy for lung cancer: a systematic review and meta-analysis
por: Wang, Zhen, et al.
Publicado: (2023)

The effects of statins in patients with advanced-stage cancers - a systematic review and meta-analysis
por: Zhou, Qiang, et al.
Publicado: (2023)

Influence of statin use on prognosis of patients with renal cell cancer: a meta-analysis
por: Liang, Wenli, et al.
Publicado: (2023)

Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies
por: Lv, Hui, et al.
Publicado: (2020)

The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment †
por: Abbasian, Mohammad Hadi, et al.
Publicado: (2022)

Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies
por: Sun, Jian-Xuan, et al.
Publicado: (2022)

Organ-specific immune checkpoint inhibitor treatment in lung cancer: a systematic review and meta-analysis
por: Yu, Shufei, et al.
Publicado: (2023)

Consolidation treatments after chemoradiotherapy in patients with locally advanced inoperable non-small cell lung cancer: a systematic review and network meta-analysis protocol
por: Zhao, Ye, et al.
Publicado: (2022)

Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients
por: Fathi, Zahra, et al.
Publicado: (2018)

Pre-Immunotherapy Contrast-Enhanced CT Texture-Based Classification: A Useful Approach to Non-Small Cell Lung Cancer Immunotherapy Efficacy Prediction
por: Shen, Leilei, et al.
Publicado: (2021)

Particle Therapy for Non-Small Cell Lung Tumors: Where Do We Stand? A Systematic Review of the Literature
por: Wink, Krista C. J., et al.
Publicado: (2014)

Cryoablation for advanced non-small cell lung cancer: a protocol for a systematic review
por: Duan, Hua, et al.
Publicado: (2020)

Evaluation of the Lung Immune Prognostic Index in Non-Small Cell Lung Cancer Patients Treated With Systemic Therapy: A Retrospective Study and Meta-Analysis
por: Huang, Litang, et al.
Publicado: (2021)

Surgical resection, radiotherapy and percutaneous thermal ablation for treatment of stage 1 non-small cell lung cancer: protocol for a systematic review and network meta-analysis
por: Chockalingam, Arun, et al.
Publicado: (2022)

Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
por: Nelson, Kellie Lynn, et al.
Publicado: (2017)

Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
por: Xiong, Qi, et al.
Publicado: (2021)

Interactions Between ABCB1 Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients
por: Tryggvadottir, Helga, et al.
Publicado: (2018)

Sex difference in response to non-small cell lung cancer immunotherapy: an updated meta-analysis
por: Liang, Jiali, et al.
Publicado: (2022)

CDK7 is a prognostic biomarker for non-small cell lung cancer
por: Kuempers, Christiane, et al.
Publicado: (2022)

Statins and the Risk of Lung Cancer: A Meta-Analysis
por: Tan, Min, et al.
Publicado: (2013)

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?
por: Dhawan, Annika, et al.
Publicado: (2022)

The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Xu, Yangyang, et al.
Publicado: (2021)

Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor
por: Créquit, Perrine, et al.
Publicado: (2016)

CD44 and CD24 cannot act as cancer stem cell markers in human lung adenocarcinoma cell line A549
por: Roudi, Raheleh, et al.
Publicado: (2013)

Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette–Guérin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis
por: Cai, Zhiyong, et al.
Publicado: (2021)

Combined Radio- and Chemotherapy for Non-Small Cell Lung Cancer: Systematic Review of Landmark Studies Based on Acquired Citations
por: Nieder, Carsten, et al.
Publicado: (2013)

Treatment beyond progression in non-small cell lung cancer: A systematic review and meta-analysis
por: Kuo, Wei-Ke, et al.
Publicado: (2022)

Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis
por: Alifu, Muyesar, et al.
Publicado: (2023)

Predictive Radiomic Models for the Chemotherapy Response in Non-Small-Cell Lung Cancer based on Computerized-Tomography Images
por: Chang, Runsheng, et al.
Publicado: (2021)

First-Line Treatment Options for PD-L1–Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis
por: Peng, Ling, et al.
Publicado: (2021)

CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy
por: Lin, Qian, et al.
Publicado: (2022)

Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Lei, Tianyu, et al.
Publicado: (2021)

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
por: Yang, Fang, et al.
Publicado: (2022)

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zeng, Haiyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nguv0qc7jm2dfm5f9fq5e85i7c